A Study of MDL 28,574A in HIV-Infected Patients
NCT00002329
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
Celgosivir hydrochloride
Sponsor
Hoechst Marion Roussel